top of page
  • Photo du rédacteurJean Manuel Toussaint

France : Drug Eluting Stents (DES) market

Dernière mise à jour : 17 juil. 2020

DES market revenues have been flatenning over the past 3 years. In 2019, DES national tariffs (LPPR) decreased of -17.1% (€760 to €630) even though it doesn't reflect real-life tariffs, especially in public hospitals where prices are much lower. Consequently we observe a drop of -3.4% in total revenues (2018 vs 2019 : €201M.).

To get the full report, please contact-us : inquiries@ihmt-medicaldevice.com

Evolution of the Drug Eluting Stents (DES) market revenue over the past 9 years (2011-2019) with a split public and private hospitals
France : Drug Eluting Stents Market per Hospital (€, 2011-2019)
44 vues0 commentaire

Comments


bottom of page